BioNTech competitors and similar companiesClear all

BioNTech's competitors and similar companies include APEIRON Biologics, Ohm Oncology, Kite Pharma, 3sbio and Evotec.

	BioNTech BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.	APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.	Ohm Oncology Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.	Kite Pharma Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.	3sbio 3sbio (三生制药集团) is a company that develops biopharmaceuticals.	Evotec Evotec is a drug discovery alliance and development partnership company.
Founding Date	Founding Date 2008	Founding Date 2005	Founding Date 2015	Founding Date 2009	Founding Date 1993	Founding Date 1993
Type	Type Public	Type Private	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech clinical research drug development medical records oncology therapy	Tags Manufacturing & Industrial biotech drug development oncology pharma	Tags Healthcare biotech clinics drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Manufacturing & Industrial biotech drug development pharma
Locations	Locations Mainz, DE HQ Halle (Saale), DE Idar Oberstein, DE Marburg, DE Neuried, DE Planegg, DE Cambridge, US see more	Locations Wien, AT HQ	Locations Austin, US HQ	Locations Santa Monica, US HQ Amsterdam, NL Hoofddorp, NL Hayes, GB Hayes, GB El Segundo, US Emeryville, US see more	Locations George Town, KY HQ	Locations Hamburg, DE HQ Orth An Der Donau, AT Lyon, FR Toulouse, FR Göttingen, DE Köln, DE Neuried, DE see more
Employees	Employees 1,94149% increase	Employees 19	Employees 167% decrease	Employees 3,3271% increase	Employees 5,2325% decrease	Employees 4,3544% increase
Valuation ($)	Valuation ($) 32.9 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.1 b
Twitter followers	Twitter followers 79.9 k	Twitter followers 685	Twitter followers N/A	Twitter followers 4.9 k	Twitter followers N/A	Twitter followers 3.6 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 7	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 11	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 49
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 142.9	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 10.5	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 3.9
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 97.96%
Alexa Website Rank	Alexa Website Rank 137148	Alexa Website Rank 511830	Alexa Website Rank N/A	Alexa Website Rank 450305	Alexa Website Rank 31283	Alexa Website Rank 341556
Employee Rating	Employee Rating 3.3	Employee Rating N/A	Employee Rating N/A	Employee Rating 3.8	Employee Rating 3	Employee Rating 3.6
Financial
Revenue (est.)	Revenue (est.) €19b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $22.2m (FY, 2016)	Revenue (est.) ¥6.4b (FY, 2021)	Revenue (est.) €618m (FY, 2021)
Cost of goods	Cost of goods €2.9b (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥777.3m (FY, 2021)	Cost of goods (€400.9m) (FY, 2021)
Gross profit	Gross profit €16.2b (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥5.7b (FY, 2021)	Gross profit €290.6m (FY, 2021)
Net income	Net income €10.3b (FY, 2021)	Net income N/A	Net income N/A	Net income ($267.1m) (FY, 2016)	Net income ¥1.6b (FY, 2021)	Net income €215.5m (FY, 2021)
Funding
Total funding raised	Total funding raised $ 1.4b	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 85.3m	Total funding raised $ 15.2m	Total funding raised $ 953.9m